ANI PHARMACEUTICALS INC (ANIP)
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Address
210 MAIN STREET WEST
BAUDETTE, MN 56623
Founded
1996
Number of Employees
642
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | $542 | $1,960 | $4,994 | $9,961 | $4,364 |
Average Price | - | - | - | - | - | - | - | $31.45 | $29.53 | $43.46 | $67.01 | $50.28 |
# Shares Purchased | - | - | - | - | - | - | - | 17,220 | 66,369 | 114,912 | 148,644 | 86,786 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | 84.4% | 96.4% | 33.5% | -13.4% | 15.3% |
S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | 31.3% | 7.4% | 26.9% |
Excess Total Return | - | - | - | - | - | - | - | 52.8% | 59.2% | 2.1% | -20.9% | -11.6% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | 87% | 92% | 74% | 20% | 52% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)